FUS-2 Antibodies

Santa Cruz Biotechnology provides a broad selection of FUS-2 monoclonal antibodies for research focused on understanding the FUS protein's role in cellular processes. FUS-2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FUS, or Fused in Sarcoma, is a multifunctional protein involved in RNA processing, transcription regulation, and DNA repair. FUS dysregulation has been implicated in several neurodegenerative diseases and cancers, making FUS-2 monoclonal antibodies essential for studying related pathways. Understanding FUS function is vital for developing therapeutic strategies targeting associated disorders. FUS-2 monoclonal antibodies enable precise detection and analysis of FUS expression patterns across different cell types and tissues. Researchers can utilize FUS-2 monoclonal antibodies to investigate protein-protein interactions and cellular localization patterns. Advanced research techniques incorporating FUS-2 monoclonal antibodies help reveal new insights about disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by facilitating discoveries that advance our understanding of neurodegenerative diseases and cancer biology.